XTX Topco Ltd: RZLV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of XTX Topco Ltd on RZLV, newest first. How the timeline and the estimate are built.
XTX Topco Ltd held 224,431 RZLV shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 224,431 sharesChange vs previous 13F +202,226 shares
0.01% of the 13F portfolio, value $706,958.
13F-HR 0001828301-26-000005 filed by XTX Topco Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 22,205 sharesChange vs previous 13F -156,728 shares
<0.01% of the 13F portfolio, value $56,845.
13F-HR 0001828301-26-000004 filed by XTX Topco Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 178,933 sharesChange vs previous 13F -178,719 shares
0.01% of the 13F portfolio, value $459,858.
13F-HR 0001828301-26-000001 filed by XTX Topco Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 357,652 sharesChange vs previous 13F +357,652 shares
0.09% of the 13F portfolio, value $1,781,107.
13F-HR 0001828301-25-000036 filed by XTX Topco Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -95,771 shares
13F-HR 0001828301-25-000025 filed by XTX Topco Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 95,771 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $365,845.
13F-HR 0001828301-25-000023 filed by XTX Topco Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).